PDMR Dealing

CVS Group plc
29 January 2024
 

29 January 2024

 

CVS Group plc

 

("CVS" or the "Company")

 

PDMR Dealing

CVS, one of the UK's leading providers of integrated veterinary services, announces that it was notified on 26 January 2024 that Joanne Shaw, Non-executive Director of the Company purchased a total of 589 ordinary shares of 0.2p each in the Company ("Ordinary Shares") on the same date.

As a result, Joanne Shaw's total interest in the Company, including any persons closely associated, is now 589 Ordinary Shares, representing 0.001% per cent of the total voting rights of the Company.

The notification below, made in accordance with the requirements of the UK Market Abuse Regulation, provides further detail.

Contacts:

CVS Group plc                                                                                                                                via Camarco

Richard Fairman, CEO

Scott Morrison, Company Secretary

 

Peel Hunt LLP (Nominated Adviser & Broker)                                                 +44 (0)20 7418 8900

Adrian Trimmings / Michael Burke / Andrew Clark / Lalit Bose

 

   Berenberg (Joint Broker)                                                                                          +44 (0)20 3207 7800

Toby Flaux / Ben Wright / Ciaran Walsh / Milo Bonser

 

Camarco (Financial PR)                                                                                             

Geoffrey Pelham-Lane                                                                                +44 (0)7733 124 226

Ginny Pulbrook                                                                                                     +44 (0)7961 315 138

    

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Joanne Shaw

2

 

Reason for the notification

 

a)

 

Position/status

 

 

PDMR (Non-Executive Director)

b)

 

Initial notification /Amendment

 

 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

CVS Group plc

b)

 

LEI

 

 

213800J41XDQ2NX48O05

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

Ordinary shares of 0.2 pence each

 

 

GB00B2863827

 

b)

 

Nature of the transaction

 

On-market purchase

c)

 

Price(s) and volume(s)

 

 

 

Price(s) - pence

 

Volume(s)

1,696.10

589

 

 

d)

 

Aggregated information

 

- Aggregated volume

 

 

- Price

 

 

 

 

N/A - single transaction

e)

 

Date of the transaction

 

 

26 January 2024

f)

 

Place of the transaction

 

London Stock Exchange - AIM (XLON)

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 

Companies

CVS Group (CVSG)
UK 100

Latest directors dealings